Munker et al. generated a RUNX1-mutated, CN-AML cell line (CG-SH) from an AML patient and characterized its properties in vitro [6]; however, its potential to model the disease in vivo has not previously been explored. This evidence concerns the gene RUNX1 and acute myeloid leukemia.